gemcitabine and nab paclitaxel

DRUG2 trials

Sponsors

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), University of Florida

Conditions

Pancreatic CancerPancreatic Ductal Adenocarcinoma

Phase 1

Phase I/II Study of LDE225 With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer

CompletedNCT02358161

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Pancreatic Cancer

Start: 2015-09-30End: 2019-01-31Updated: 2020-01-09

Repurposing Mefloquine for Pancreatic Cancer Treatment

Not yet recruitingNCT07875907

University of FloridaPancreatic Ductal Adenocarcinoma

Start: 2026-11-01End: 2031-01-01Target: 36Updated: 2026-10-15

Related Papers

Phase I/II study of LDE225 in combination with gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer.

Journal of Clinical Oncology2021-05-204 citations